DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (179)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 179   Next >>

Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-08-27

Patient: female, weighing 67.6 kg (148.7 pounds)

Reactions: Nodule, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 90 mg, unk, 1 hr infusion on d2,d4,d6,d8,d10
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-01

Cytarabine
    Dosage: 1.80 g, unk,continuous infusion d1 to d10
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-30

Idarubicin HCL
    Dosage: 48 mg, unk, on d1,d3,d5
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-30

Other drugs received by patient: Fluconazole; Valaciclovir; Ceftazidime; Oxazepam; Leucoplenin



Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male, weighing 90.0 kg (198.0 pounds)

Reactions: Dyspnoea, Tachycardia, Atrial Fibrillation, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1470 mg
    Start date: 2012-08-10

Daunorubicin HCL
    Dosage: 570 mg
    End date: 2012-08-06



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female

Reactions: Pyrexia, Pupils Unequal, Cerebral Ischaemia, Pleural Effusion, Brain Oedema, Intracranial Pressure Increased, Staphylococcal Bacteraemia, Pupil Fixed, Blood Pressure Systolic Decreased, Pupillary Reflex Impaired, Cerebral Artery Stenosis, Brain Stem Haemorrhage, Brain Herniation, Hyperreflexia, Ascites, Convulsion, Venoocclusive Disease, Bacteraemia, Respiratory Failure, Meningitis Bacterial, Mental Disorder, Acute Myeloid Leukaemia Recurrent

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 52 mg/m2, dose level 3
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-07-13
    End date: 2012-07-17

Cytarabine
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-07-12



Possible Cytarabine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: female, weighing 87.8 kg (193.2 pounds)

Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Cytarabine
    Dosage: 1.87 g, cyclic
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, unk
    Indication: Mantle Cell Lymphoma

Mesna
    Dosage: 600 mg/m2, unk
    Indication: Mantle Cell Lymphoma

Methotrexate
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: 1 mg/m2, cyclic
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: 0.7 mg/m2, cyclic
    Start date: 2012-03-19

Velcade
    Dosage: 2.77 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-12-31

Velcade
    Dosage: 0.7 mg/m2, cyclic

Velcade
    Dosage: 0.7 mg/m2, cyclic
    Start date: 2012-02-26

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-08-16

Patient: male, weighing 90.0 kg (198.0 pounds)

Reactions: Dyspnoea, Tachycardia, Atrial Fibrillation, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1470 mg
    End date: 2012-08-10

Daunorubicin HCL
    Dosage: 570 mg
    End date: 2012-08-06



Possible Cytarabine side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease

Cytarabine
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Dexamethasone
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy



Possible Cytarabine side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease

Cytarabine
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Dexamethasone
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-13

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Disseminated Intravascular Coagulation, Hypotension, Continuous Haemodiafiltration, Pyrexia, Tumour Lysis Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 157 mg

Daunorubicin HCL
    Dosage: 80 mg

Etoposide
    Dosage: 15.7 mg



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-08-13

Patient: male

Reactions: Pyrexia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 500 mg/m2, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2012-06-25

Rituximab
    Dosage: 375 mg/m2, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2012-06-25

Treanda
    Dosage: 70 mg/m2, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2012-06-26

Other drugs received by patient: Fluconazole; Allopurinol; Tetracosactide; Sulfamethoxazole and Trimethoprim; Darbepoetin Alfa; Pegfilgastrim; Amoxicillin and Clavulanate Potassium



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-13

Patient: female, weighing 64.6 kg (142.1 pounds)

Reactions: Pulmonary Haemorrhage, Blood Culture Positive, Tachycardia, Hypotension, Bacterial Infection, Pyrexia, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 17000 mg
    End date: 2012-07-25

Etoposide
    Dosage: 1275 mg
    End date: 2012-07-25



Possible Cytarabine side effects in male

Reported by a physician from France on 2012-08-09

Patient: male, weighing 75.5 kg (166.1 pounds)

Reactions: Diarrhoea Haemorrhagic, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carmustine
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-18
    End date: 2012-05-18

Cytarabine
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-19
    End date: 2012-05-22

Etoposide
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-19
    End date: 2012-05-22

Mabthera
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-01-01
    End date: 2012-05-01

Mabthera
    Start date: 2012-05-18
    End date: 2012-05-18

Melphalan
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-23
    End date: 2012-05-23

Other drugs received by patient: Nexium; Leucovorin Calcium; Valacyclovir Hydrochloride



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-08-09

Patient: male

Reactions: Respiratory Failure, Chills, Pancytopenia, Condition Aggravated, Pyrexia, Lung Infection Pseudomonal, Septic Shock, Oxygen Saturation Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Alkeran
    Dosage: 234mg per day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-15
    End date: 2012-02-15

Carmustine
    Dosage: 500mg per day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-10
    End date: 2012-02-10

Cytarabine
    Dosage: 668mg per day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-11
    End date: 2012-02-14

Etoposide
    Dosage: 167mg per day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-11
    End date: 2012-02-14



Possible Cytarabine side effects in 46 year old female

Reported by a individual with unspecified qualification from United States on 2012-08-08

Patient: 46 year old female

Reactions: Dyspnoea, Pain in Extremity, Myelodysplastic Syndrome, General Physical Health Deterioration, Pyrexia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Skin Discolouration, Central Nervous System Infection, Small Intestinal Haemorrhage, Cough

Adverse event resulted in: death

Drug(s) suspected as cause:
Carmustine
    Indication: Diffuse Large B-Cell Lymphoma

Carmustine
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: 400 ug, intravenous, every two months
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Idarubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Melphalan (Melphalan) (Melphalen)
    Indication: Diffuse Large B-Cell Lymphoma

Melphalan Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab (Rituximab) (Rituximab)
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab (Rituximab) (Rituximab)
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma



Possible Cytarabine side effects in 66 year old male

Reported by a physician from France on 2012-08-07

Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Cytarabine
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-28
    End date: 2012-03-02

Etoposide
    Dosage: 400 mg/m2 daily; uid/qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-28
    End date: 2012-03-02

Melphalan Hydrochloride
    Dosage: 250 mg total dose
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-03-03

Treanda
    Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-27
    End date: 2012-02-28

Treanda
    Indication: non-Hodgkin's Lymphoma



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-06

Patient: female, weighing 64.6 kg (142.1 pounds)

Reactions: Hypotension, Tachycardia, Bacterial Infection, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 17000 mg
    End date: 2012-07-25

Etoposide
    Dosage: 1275 mg
    End date: 2012-07-25



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-08-01

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Malaise, Diarrhoea, Pyrexia, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 210 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-29

Clofarabine
    Dosage: 18 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-26

Cytarabine
    Dosage: 3600 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-26



Possible Cytarabine side effects in female

Reported by a physician from Germany on 2012-07-31

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: Abdominal Pain, Malaise, Vomiting, General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Asparaginase

Cytarabine

Methotrexate

Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    Start date: 2012-04-16

Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-14
    End date: 2012-04-14

Other drugs received by patient: Acyclovir; Cotrim



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-31

Patient: female, weighing 29.9 kg (65.8 pounds)

Reactions: Sphingomonas Paucimobilis Infection, Contusion, Clostridium Test Positive, Tachycardia, Rectal Haemorrhage, Pyrexia, Resuscitation, Heart Rate Decreased, Balance Disorder, Abdominal Distension, Pain in JAW, Lethargy

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: 70 mg
    End date: 2012-07-12

Daunorubicin HCL
    Dosage: 52 mg
    End date: 2012-07-20

Dexamethasone
    Dosage: 132 mg
    End date: 2012-07-23

Methotrexate
    Dosage: 12 mg
    End date: 2012-07-20

PEG-L-Asparaginase (Pegaspargase, Oncospar)
    Dosage: 2680 mg
    End date: 2012-07-16

Vincristine Sulfate
    Dosage: 3.1 mg
    End date: 2012-07-20



Possible Cytarabine side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 46 year old female

Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carmustine

Cyclophosphamide
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine

Cytarabine
    Dosage: 1.5 g/d/m2 (1 cycle)

Doxorubicin Hydrochloride
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide

Idarubicin HCL
    Dosage: 12 mg/d/m2 (1 cycle)

Melphalan Hydrochloride

Oncovin
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab

Vorinostat
    Dosage: 1 cycle
    Administration route: Oral



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30

Patient: male

Reactions: Confusional State, Pulmonary Hypertension, Febrile Infection, Pyrexia, Mixed Liver Injury, Multi-Organ Failure, Enterovesical Fistula, Bone Marrow Failure, Pneumothorax, Acute Respiratory Distress Syndrome, Thrombocytopenia, Metabolic Acidosis, Haemoptysis, Intestinal Obstruction, Appendicitis, Lung Disorder, Renal Impairment, Zygomycosis, Respiratory Acidosis, Oliguria, Aspergillosis, Sinus Tachycardia, Septic Shock, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 10 mg
    Administration route: Oral
    Start date: 2008-03-19

Afinitor
    Dosage: 10 mg
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2008-03-13

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2008-03-13
    End date: 2008-03-19

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2008-03-13
    End date: 2008-03-15

Other drugs received by patient: Vancomycin



Possible Cytarabine side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient: 46 year old female

Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Carmustine
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Idarubicin HCL
    Dosage: 12 mg/m2, unk
    Indication: Myelodysplastic Syndrome

Oncovin
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Suberoylanilide Hydroxamic Acid
    Dosage: 500 mg, tid
    Administration route: Oral
    Indication: Myelodysplastic Syndrome

Other drugs received by patient: Radiotherapy



Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-07-26

Patient: male, weighing 13.9 kg (30.6 pounds)

Reactions: Capillary Nail Refill Test Abnormal, Tachycardia, Anaphylactic Reaction, Hypotension, Drug Hypersensitivity, Pyrexia, Respiratory Distress

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 7200 mg

Elspar
    Dosage: 3600 unit
    End date: 2012-07-18



Possible Cytarabine side effects in 17 year old male

Reported by a physician from United States on 2012-07-26

Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)

Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-27

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Daunorubicin Hydrochloride
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-26



Possible Cytarabine side effects in female

Reported by a physician from France on 2012-07-25

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Abdominal Pain, Confusional State, Chills, Pyrexia, Convulsion, Loss of Consciousness, Cerebral Hypoperfusion, Diarrhoea, Gamma-Glutamyltransferase Increased, Sepsis

Drug(s) suspected as cause:
Clofarabine
    Dosage: 54.5 mg, on d2-d3-d4-d5 and d6
    Indication: Acute Leukaemia
    Start date: 2012-06-26
    End date: 2012-06-30

Cytarabine
    Dosage: 1825 mg, on d1-d2-d3-d4-and d5
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25
    End date: 2012-06-29

Filgrastim
    Dosage: 385 mg, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-05

Other drugs received by patient: Plitician; Ambiosome; Actrapid; Magnesium Sulfate; Aluminum Hydroxide and Magnesium Trisilicate; Decan; Plitician; Acetaminophen; Cernevit-12; Miconazole; Tiorfan; Zofran



Possible Cytarabine side effects in 11 year old female

Reported by a physician from United States on 2012-07-23

Patient: 11 year old female, weighing 54.7 kg (120.3 pounds)

Reactions: Pancytopenia, Pyrexia, Caecitis, Enterocolitis Infectious

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-10
    End date: 2012-06-04

Cytarabine

Etoposide
    Dosage: 150 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-10
    End date: 2012-06-04

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-10
    End date: 2012-06-08



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis, Laryngospasm

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, on days 1-7
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2, on days 1-5
    Indication: Acute Myeloid Leukaemia

Idarubicin Hydrochloride
    Dosage: 12 mg/m2, on days 1-3
    Indication: Acute Myeloid Leukaemia

Mitoxantrone Hydrochloride
    Dosage: 10 mg/m2, on days 1-5
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in

Reported by a physician from United Kingdom on 2012-07-17

Patient:

Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from Netherlands on 2012-07-13

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Febrile Neutropenia, Pyrexia, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: last dose prior to sae 05/jun/2012
    Start date: 2012-06-05

Cisplatin
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Cytarabine
    Dosage: last dose prior to sae 06/jun/2012
    Start date: 2012-06-06

Cytarabine
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-05

Dexamethasone
    Dosage: last dose prior to sae 07/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Dexamethasone
    Dosage: last dose prior to sae 08/jun/2012
    Start date: 2012-06-05

Mabthera
    Dosage: last dose prior to sae 08/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-08

Mabthera
    Dosage: last dose prior to sae 09/jun/2012
    Start date: 2012-06-09

Other drugs received by patient: Augmentin '125'; Ciprofloxacin HCL; Nexium; Fungizone; Keppra; Keppra; Valganciclovir; Allopurinol



Possible Cytarabine side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-11

Patient: 61 year old female

Reactions: Rash Pustular, Nausea, Pyrexia, Oral Herpes, Erythema, Sensorimotor Disorder, Haemodialysis, Stem Cell Transplant, Mucosal Inflammation, Epidermal Necrosis, Mental Disorder, Nervous System Disorder, Renal Tubular Necrosis, Blister, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine

Other drugs received by patient: Vancomycin Hydrochloride; Melphalan Hydrochloride; Carmustine; Etoposide; Cefepime Hydrochloride



Possible Cytarabine side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014